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Peroxiredoxin 1 (PRDX1) is an antioxidant enzyme that, when secreted, can act as a 
proinflammatory signal. Here we studied the regulation of intracellular PRDX1 by 
lipopolysaccharide (LPS) and interferon-gamma (IFNγ) in the RAW 264.7 mouse macrophage 
cell line. While LPS or IFNγ alone did not affect PRDX1 protein levels, their combination led 
to an almost complete loss of the PRDX1 dimer. This was likely mediated by the increased 
production of nitric oxide (NO) as it was reversed by the NO synthase inhibitor ʟ-N-
methylarginine (ʟ-NMMA), while a NO-releasing agent decreased PRDX1 levels. Inhibition of 
the proteasome with MG132 also prevented the loss of the PRDX1 dimer, suggesting that 
the decrease is due to a NO-activated proteasomal degradation pathway.  
By contrast with the decrease in protein levels, LPS increased PRDX1 mRNA and this effect 
was amplified by IFNγ. Two other Nrf2 target genes, thioredoxin reductase (TXNRD1) and 
heme oxygenase (HMOX1), were also induced by LPS but IFNγ did not increase their 
expression further.  This study shows that inflammation differentially regulates PRDX1 at the 














Peroxiredoxins (PRDX) are highly conserved thioredoxin (TXN) peroxidases [1], reducing 
peroxides including hydrogen peroxide (H2O2) and peroxynitrite, and are one of the most 
abundant cellular proteins, comprising 0.1-0.8% of the total soluble protein in mammalian 
cells [2]. Intracellular PRDXs have anti-inflammatory roles as shown by several studies using 
overexpression or knock-out mice (for instance [3, 4]). On the other hand, extracellular 
PRDXs can trigger production of inflammatory cytokines by macrophages [5, 6], acting as 
danger signals, and have been implicated in the initiation of sterile inflammation in cerebral 
ischemia [7]. 
We have previously shown that stimulation of macrophages with the Toll-like receptor 4 
(TLR4) agonist lipopolysaccharide (LPS) leads to the release of preformed PRDX1 and PRDX2 
[6, 8]. However, only the disulfide-linked homodimers of PRDX1 and 2 are secreted; the 
monomers are not secreted and cysteine mutants that cannot form dimers are not secreted 
[8]. 
Interferon-gamma (IFNγ) is a Th1 cytokine that acts in synergy with LPS to augment TLR4-
mediated proinflammatory responses [9] and has an essential role in  the innate immune 
responses against bacteria [10, 11].  A key effect of the combined stimulation with IFNγ and 
LPS in macrophages is the induction of inducible nitric oxide (NO) synthase (iNOS) and 
subsequent NO production [12], which also participates in the innate immunity against 
intracellular pathogens [13, 14]. 
In this study, we investigated the effect of LPS and IFNγ on the expression of PRDX1 in the 
RAW 264.7 macrophage cell line, focusing on the oxidized dimer. To investigate the role of 
NO in the regulation of PRDX1, we measured NO production and used specific inhibitors of 
iNOS. Finally, because of earlier studies showing that PRDX1 is susceptible to proteasomal 
degradation following nitrosative stress  [15], and the proteasome can be activated by 
reactive nitrogen species [16], we tested the role of the proteasome using its inhibitor 
MG132. Our results uncover a novel pathway of NO-dependent, proteasome-dependent 
regulation of PRDX1 levels that can provide new insights into the mechanisms of redox 





All chemicals and reagents were purchased from Sigma-Aldrich Corporation (St. Louis, USA) 
unless otherwise stated. Recombinant rat IFNγ was from R&D Systems, Minneapolis, MN. 
Cell culture and treatment 
RAW 264.7 cells were maintained at 37°C and 5% CO2 in RPMI containing 2mM L-glutamine, 
supplemented with 50 U/ml penicillin, 50 µg/ml streptomycin (Thermo Fisher Scientific, 
Waltham, USA) and 10% (v/v) heat inactivated Foetal Calf Serum. For experiments, 1.25x105 
cells/ml were seeded in 24-well plates and incubated overnight to allow adhesion. 
Stimulations were performed as indicated in the text. 
 LPS was dissolved in PBS at 200 µg/ml, then diluted in medium to have the final 
concentration. IFNγ was prepared from a stock solution at 2x106 U/ml in culture medium.  
LPS was used at 10ng/ml as this study followed up from previous studies from this 
laboratory where gene expression analysis revealed induction of PRDX1 mRNA at 6h [17].  
The IFNγ concentration of 100U/ml was also used in our previous work on the same cells 
[6]. Macrophage pre-incubation with IFNγ is typically used to increase LPS-induced 
macrophage activation, in terms of cytokine production and iNOS. In the literature, times of 
incubation vary from 16h to few hours. We preincubated with IFNγ for 2h based on previous 
works [18] and, since this pre-treatment increased nitrate production in our experimental 
model, this scheme was used for all the experiments. 
Western blot 
Cells were gently washed in PBS which was removed completely before 150μl 1.5% Laemmli 
sample buffer containing 50 mM N-ethylmaleimide (NEM) (to prevent modification of 
protein free thiols) was added to each well. After centrifugation at 5000 x G for 5 minutes at 
4°C to remove any remaining cells or cellular debris, proteins were analysed by SDS-PAGE 
(12% acrylamide) under non-reducing conditions, transferred onto nitrocellulose 
membranes (GE Healthcare Life Sciences, Little Chalfont, UK) and probed for PRDX1 or 
PRDX2 (rabbit polyclonal antibodies were a generous gift from Dr Eva-Maria Hanschmann, 
University of Greifswald, Germany).  Membranes were then incubated with an anti-rabbit 
HRP-linked secondary antibody (Sigma-Aldrich) at 1:25,000 and developed using ECL 
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Western Blot Analysis System (GE Healthcare). Blots were stripped with Restore™ Western 
Blot Stripping buffer (Thermo Fisher Scientific) and reprobed with rabbit monoclonal anti-
GAPDH antibodies (Cell Signaling Technology, Danvers, Massachusetts, USA). All primary 
antibodies were diluted 1:1,000. Densitometry was performed on blots using ImageJ 1.48v. 
Samples represent biological replicates, i.e. each sample in the various lanes was an 
independent cell culture well processed independently. 
Measurement of NO production  
Nitrite levels were measured by the Griess reaction [19]. The assay was performed on cell 
supernatants using Griess reagent system (G2930) (Promega Corporation, Madison, 
Wisconsin, USA) according to the manufacturer’s instructions. 
TaqMan RT-qPCR 
Total RNA was extracted from cells using QIAzol (QIAGEN, Hilden, Germany), following 
manufacturer’s instructions. Reverse transcription (RT) and TaqMan qPCR analysis of PRDX1 
(Mm01621996_s1), TXNRD1 (Mm00443675_m1) and HMOX1 (Mm00516005_m1) gene 
expression were performed as previously reported [17]. Data were normalised to HPRT1 
(Mm00446968_m1) and expressed as fold change vs one control sample. All TaqMan gene 
expression assays were purchased from Life Technologies (Carlsbad, USA). 
 
Results 
PRDX1 loss occurs following IFN/LPS stimulation 
Addition of LPS or IFNγ independently did not affect intracellular levels of PRDX1. In 
contrast, treatment with IFNγ 2h prior to addition of LPS and further culture for 24 h caused 
loss of the PRDX1 dimer (Fig. 1A). Either LPS or IFNγ alone did not affect intracellular PRDX1 
monomer or dimer, following normalization for protein content using GAPDH as loading 
control, as shown in the densitometric analysis in Fig. 1B, whereas IFN/LPS markedly 
decreased the amount of PRDX1 dimer, an effect that was not evident for the monomer. 
The loss of intracellular PRDX1 dimer was not due to its release in the extracellular 
environment since no PRDX1 could be detected in the supernatants of IFN/LPS-stimulated 
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cells (data not shown). Identical results were obtained with the other 2-Cys PRDX, PRDX2, 
except that no PRDX2 monomer was detected in any of the samples (Supplementary Fig. 1).   
To further investigate the decrease in the levels of PRDX1 following exposure to IFN/LPS, a 
time course was performed over 24h. The results, shown in Fig. 1C, indicate that the 
decrease in PRDX1 dimer is first observed at 18h, and is significantly reduced by 24h post-
stimulation, in the absence of any significant change for the monomer. 
 
Role of NO and proteasomal degradation in the loss of PRDX1 dimer 
A key aspect in the synergy between IFNγ and LPS is the upregulation of iNOS [12], 
therefore the nitrite content of the time course supernatants was investigated as an 
indicator of NO production. As shown in Fig. 2A, the time-course of nitrite production 
paralleled that of the decrease in PRDX1 levels (Fig. 1C), peaking at 24h, suggesting a 
potential link between the two phenomena. Of note, stimulation using either LPS or IFNγ 
alone did not induce nitrite production (Fig. 2B), paralleling the effect on PRDX1 (Fig. 1B). 
Therefore, we tested inhibitors of iNOS in our model, firstly looking at their effects on nitrite 
production. In these experiments, cells were incubated with 0.3 mM N-G-nitro-L-arginine 
methyl ester (ʟ-NAME) or ʟ-N-methylarginine (ʟ-NMMA) for 1h prior to the 2h stimulation with 
IFNγ, and subsequent 24h stimulation with LPS. Nitrite production was then measured in cell 
culture supernatants. The results shown in Fig. 2C indicate that, in this model, ʟ-NMMA was 
the most effective iNOS inhibitor to significantly reduce nitrite production. It is possible that 
ʟ-NAME is less effective than ʟ-NMMA in our model as ʟ-NAME needs to be hydrolysed to its 
active free acid form by esterases [20]. 
To investigate the role of iNOS in the PRDX1 decrease in cells treated with IFN/LPS, we 
tested the effect of 1 mM ʟ-NMMA added 1h prior to IFN/LPS stimulation. As shown in Fig. 
3A, ʟ-NMMA limited the IFN/LPS-induced loss of PRDX1 dimer. To further confirm that the 
observed decrease in the levels of PRDX1 could be attributed to NO production, we 
investigated the effect of the NO donor (Z)-1-[N-(2-aminoethyl)-N-(2-
ammonioethyl)amino]diazen-1-ium-1,2-diolate (DETA-NONO) on PRDX1 levels. Of the 
available NO donors, DETA-NONO was selected due to its long half-life and steady NO 
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release [21]. As shown in Fig. 3B, DETA-NONO markedly decreased PRDX1 levels.  The 
possible role of the proteasome in the degradation of PRDX1 was investigated using the 
proteasome inhibitor MG132. Addition of MG132 1h prior to IFN/LPS prevented the loss of 
PRDX1 dimer induced by IFN/LPS (Fig. 3C). 
 
PRDX1 gene expression is induced by iNOS 
In a different set of experiments, we investigated the effect of IFN/LPS on PRDX1 gene 
expression by PCR. As shown in Fig. 4A, the combination of IFN/LPS (2h preincubation with 
IFNγ before addition of LPS and further 6 h culture) increased PRDX1 mRNA levels to almost 
double that of LPS alone, which was not expected as the same conditions caused a large 
reduction of the PRDX1 dimer (Fig. 1). Because PRDX1 is a Nrf2 target gene, we also 
measured two other prototypical Nrf2 target genes, HMOX1  [22] and TXNRD1  [23]. As 
shown in Fig. 4, panels B and C, both genes were induced by LPS alone, with IFNγ having no 
additional effect. To investigate the role of iNOS-generated NO in the observed increase in 
PRDX1 mRNA, we treated cells with ʟ-NMMA 1h prior to 18h IFN/LPS stimulation (2h 
preincubation with IFNγ before addition of LPS and further 18 h culture). As shown in Fig. 
4D, IFN/LPS-induced PRDX1 mRNA was significantly reduced as a result of iNOS inhibition. 
 
Discussion 
The results presented in this study describe a mechanism by which IFN/LPS, but not either 
alone, decrease PRDX1 protein levels in macrophages possibly by an iNOS-activated 
proteasomal pathway. Furthermore, our results demonstrate that PRDX1 gene expression is 
induced by IFN/LPS, an effect that is also, at least in part, mediated by iNOS. Interestingly, 
previous work by Diet et al. [24], while showing an induction of PRDX1 mRNA by IFN/LPS , 
did not report any change in total PRDX1 protein levels. There are, however, several 
differences between our study and that of Diet et al. [24]. First of all we used RAW 264.7 
cells instead of bone marrow-derived macrophages [24]. Secondly, the previous study was 
primarily focused on mRNA expression and the level of PRDX was not specifically 
investigated (with only one protein lane shown). More importantly, we have used gels run in 
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non-reducing conditions to distinguish between the PRDX1 monomer and the disulfide-
linked dimer because we were particularly interested in the dimer that is the secreted form 
in macrophages, as we have extensively shown elsewhere [6, 8, 25]. Given that we found 
that the loss of PRDX1 occurs preferentially at the level of the dimer, measuring total 
PRDX1, as it would happen with reducing SDS-PAGE where dimers are all reduced to 
monomers, could mask the effect on the dimer.  
The experiments reported here also suggest that the loss of PRDX1 is linked to induction of 
iNOS which would activate proteasomal degradation as shown by Grune et al. with 
aconitase  [26]. Our hypothesis is also in agreement with a previous study showing that 
PRDX1 is polyubiquitinated by the ubiquitin protein ligase E6AP, which is activated by 
nitrosative stress [15]. 
It should be noted, however, that there are alternative explanations for the decrease of the 
PRDX dimer, such as overoxidation to an over-oxidized form of the monomer (e.g. 
sulfonylated or nitrosylated PRDX) that thus cannot form the dimer; it is also possible that 
an over-oxidized dimer is formed, but this may not be recognized by the antibody with the 
same efficiency as the fully-reduced monomer. In the case of PRDX2, this is suggested by the 
microheterogeneity of the monomer in Supplementary Fig. 1. We noted this 
microheterogeneity before and attributed this to the presence of a glutathionylated dimer 
[6]. 
A further limitation of this work was that L-NMMA only inhibited NO production, as 
detected by extracellular nitrite formation with the Griess’ reagent, only by one third while 
the effect on PRDX stabilization is by over 60%. This may be due to various factors that can 
interfere with the formation of nitrites, and studies with other techniques for measuring NO 
more specifically could address the issue. 
Our finding that LPS-induced PRDX1 mRNA is increased by IFNγ at least partially through NO 
supports the hypothesis of a requirement for iNOS-derived NO in the activation of Nrf2, the 
transcription factor that regulates the transcription of PRDX1 [24, 27, 28]. However, 
concluding that IFNγ/LPS induces PRDX1 mRNA through iNOS-mediated Nrf2 activation 
would be an oversimplification. First of all, as shown in Fig. 4, LPS alone increases PRDX1 
mRNA without increasing NO (Fig. 2B). Second, the synergy between IFNγ and LPS was not 
10 
 
observed for two other Nrf2 target genes, HMOX1 and TXNRD1, where IFNγ did not have an 
effect in addition to that of LPS. The fact that NO, or reactive oxygen species (ROS), are not 
the only mediators of LPS-induced Nrf2 activation has already been demonstrated by 
Cuadrado et al. [29] who showed that Nrf2 activation by LPS can take place in the absence 
of its redox-sensitive regulator Keap1. However, given the inhibitory effect of L-NMMA on 
PRDX1 mRNA induction by IFNγ/LPS, we can conclude that both NO-dependent and 
independent pathways contribute to the increase in gene expression by IFNγ/LPS. 
Further studies will be needed to investigate the biological consequence of the loss of 
PRDX1 dimer after IFNγ/LPS. It is tempting to frame this observation in the context of innate 
immunity against intracellular pathogens. The primary function of PRDX1 is to eliminate 
H2O2, and peroxides are a major means by which macrophages kill mycobacteria [30]. The 
same study showed that mycobacterial PRDX is a major defence mechanism [30]. One could 
therefore hypothesize that PRDX degradation is part of the mechanisms by which IFNγ and 
LPS promote oxidative killing of pathogens. The hypothesis outlined in the graphical abstract 
attempts to put our findings in this context and may help designing future studies to 
investigate the biological significance of PRDX regulation by cytokines. 
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Figure 1. PRDX1 loss following IFN/LPS stimulation. 
(A) Representative Western blot analysis of intracellular PRDX1 in control cells (lanes 1-3) or 
cells treated for 24h with 100U/ml IFNγ (lanes 4-6), 10ng/ml LPS (lanes 7-9) or both 
(IFN/LPS, lanes 10-12).  (B) Densitometric analysis of intracellular PRDX1 dimer (white bars) 
and monomer (black bars) in cells treated for 24h with IFNγ and LPS, normalised for loading 
by comparison to GAPDH levels. (C) Intracellular PRDX1 from cells treated with IFNγ and LPS 
for 6-24h (white bars, dimer; black bars, monomer). Data are mean ± SD of PRDX1/GAPDH 
densitometric ratio from two independent experiments (B: control, n=5, LPS, n=6; IFN, n=3; 
IFN/LPS, n=6; C: control, n=4; all other groups, n=6). **P<0.01, *P<0.05 versus respective 





Figure 2. IFN/LPS-induced nitrite production and inhibition by L-NMMA. 
Nitrite levels were measured in supernatants from RAW 264.7 cells. (A) Time course of 
nitrite production by cells stimulated for 2h with 100U/ml IFNγ, then 10ng/ml LPS for the 
time indicated (n=6). (B) Nitrite production from cells stimulated with either IFNγ, LPS or 
IFN/LPS for 24h (n=3). (C) Nitrite production from cells incubated with 0.3mM  ʟ-NAME or ʟ-
NMMA  for 1h prior to IFN/LPS stimulation for 24h (n=9).  Data are mean ± SD. **P<0.01, 
***P<0.001, ****P<0.0001 by one-way ANOVA and Dunnett's (A,B) or Tukey’s (C) multiple 






Figure 3. Inhibition of iNOS and proteasome prevent IFN/LPS-induced PRDX1 protein 
degradation and NO donor induces PRDX1 loss. 
Representative Western blot (left) and densitometric analysis (right) of PRDX1 Western 
blots, normalised for equal loading with GAPDH densitometry. (A) Cells treated for 1h with 
1mM ʟ-NMMA, then 2h with 100U/ml IFNγ and 24h with 10ng/ml LPS. (B) Cells treated  for 
24h with 0.2mM DETA-NONO. (C) Cells incubated for 1h with 0.2μM MG132, then 2h with 
100U/ml IFNγ and 24h with 10ng/ml LPS. White bars, PRDX1 dimer; black bars, PRDX1 
monomer.  Data are mean ± SD of PRDX1/GAPDH densitometric ratio (A, C, n=3-6; B, n=3). 
A, C: *P<0.05, ***P<0.001, ****P<0.0001 by one-way ANOVA and Tukey's multiple 










Supplementary Fig. 1. Western blot analysis of intracellular PRDX1 (top) and PRDX2 
(bottom) protein from RAW 264.7 control cells (lanes 1-2) or cells treated for 24h with 
10ng/ml LPS (lanes 3-5), 500ng/ml PMA (lanes 6-8; PMA is not relevant for the present 
paper but is present to avoid cutting and pasting the Western blot picture), 100U/ml IFNγ 
(lanes 9-11) or 10ng/ml LPS after pre-treatment for 2h with 100U/ml IFNγ (lanes 12-14). The 
two Western blots represent two different gels, not the same membrane stripped and re-
probed with a different antibody. 
